ENCORAFENIB for Thyroid cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 115 adverse event reports in the FDA FAERS database where ENCORAFENIB was used for Thyroid cancer.
Most Reported Side Effects for ENCORAFENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 1,004 | 11.7% | 989 | 60 |
| Off label use | 989 | 11.6% | 165 | 186 |
| Nausea | 758 | 8.9% | 38 | 213 |
| Fatigue | 685 | 8.0% | 54 | 167 |
| Diarrhoea | 574 | 6.7% | 37 | 221 |
| Neoplasm progression | 548 | 6.4% | 163 | 107 |
| Pyrexia | 539 | 6.3% | 34 | 241 |
| Product use in unapproved indication | 506 | 5.9% | 77 | 63 |
| Vomiting | 429 | 5.0% | 24 | 173 |
| Rash | 414 | 4.8% | 22 | 83 |
| Serous retinal detachment | 297 | 3.5% | 13 | 56 |
| Arthralgia | 281 | 3.3% | 13 | 56 |
| Malaise | 266 | 3.1% | 30 | 85 |
| Decreased appetite | 261 | 3.1% | 32 | 111 |
| Asthenia | 213 | 2.5% | 29 | 85 |
Other Indications for ENCORAFENIB
Malignant melanoma (2,591)
Colon cancer (1,294)
Metastatic malignant melanoma (865)
Colorectal cancer metastatic (362)
Colorectal cancer (289)
Product used for unknown indication (241)
Neoplasm malignant (199)
Metastasis (168)
Colon cancer metastatic (134)
Rectal cancer (100)
Other Drugs Used for Thyroid cancer
LENVATINIB (2,668)
CABOZANTINIB S-MALATE (1,615)
VANDETANIB (591)
DABRAFENIB (583)
TRAMETINIB DIMETHYL SULFOXIDE (482)
SORAFENIB (399)
LEVOTHYROXINE (299)
PAZOPANIB (264)
PRALSETINIB (199)
CABOZANTINIB (125)